HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anurag Mehta Selected Research

human CCND1 protein

1/2014Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anurag Mehta Research Topics

Disease

29Neoplasms (Cancer)
01/2022 - 04/2006
12Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 01/2020
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 07/2014
11Breast Neoplasms (Breast Cancer)
10/2021 - 01/2015
8Adenocarcinoma of Lung
01/2022 - 01/2013
5Lung Neoplasms (Lung Cancer)
01/2022 - 01/2018
5COVID-19
01/2022 - 04/2020
5Neoplasm Metastasis (Metastasis)
10/2021 - 12/2015
4Atherosclerosis
01/2022 - 01/2018
4Coronary Artery Disease (Coronary Atherosclerosis)
11/2021 - 01/2019
4Carcinoma (Carcinomatosis)
01/2021 - 01/2014
3Inflammation (Inflammations)
11/2021 - 01/2018
3Adenocarcinoma
08/2021 - 10/2015
3Hypertension (High Blood Pressure)
06/2021 - 01/2021
3Triple Negative Breast Neoplasms
01/2020 - 01/2014
3Coronary Disease (Coronary Heart Disease)
01/2020 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 01/2021
2Myocardial Infarction
11/2021 - 11/2020
2Prostatic Neoplasms (Prostate Cancer)
08/2021 - 07/2015
2Diabetes Mellitus
05/2021 - 01/2019
2Infections
01/2021 - 04/2006
2Stroke (Strokes)
11/2020 - 01/2020
2Anemia
10/2019 - 07/2019
2Ovarian Neoplasms (Ovarian Cancer)
03/2019 - 01/2018
2Lactic Acidosis
01/2019 - 11/2018
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2018 - 01/2018
2Lymphoma (Lymphomas)
01/2018 - 07/2017
2Multiple Myeloma
10/2015 - 09/2011
1Giant Cell Tumors (Giant Cell Tumor)
01/2022
1Cysts
10/2021
1Sarcoma (Soft Tissue Sarcoma)
09/2021
1Carcinoid Tumor (Carcinoid)
09/2021
1Glomus Tumor (Glomus Tumors)
09/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2021
1Insulin Resistance
05/2021
1ST Elevation Myocardial Infarction
05/2021

Drug/Important Bio-Agent (IBA)

12Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2014
8ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2013
7CalciumIBA
01/2022 - 01/2018
5Lipoprotein(a)IBA
07/2022 - 01/2020
4Anaplastic Lymphoma KinaseIBA
06/2022 - 04/2013
4LDL CholesterolIBA
12/2021 - 01/2020
4oxidized low density lipoproteinIBA
12/2021 - 01/2020
4Proteins (Proteins, Gene)FDA Link
09/2021 - 07/2018
4DNA (Deoxyribonucleic Acid)IBA
11/2020 - 09/2016
3Tyrosine Kinase InhibitorsIBA
06/2022 - 01/2020
3human ERBB2 proteinIBA
01/2022 - 11/2020
3Cell-Free Nucleic AcidsIBA
12/2021 - 10/2020
3Pharmaceutical PreparationsIBA
12/2021 - 11/2018
3LipidsIBA
12/2021 - 01/2019
3Hormones (Hormone)IBA
10/2021 - 01/2015
3Biological ProductsIBA
05/2021 - 04/2013
3CrizotinibIBA
01/2020 - 09/2017
3Progesterone Receptors (Progesterone Receptor)IBA
01/2015 - 01/2009
2Phenobarbital (Luminal)FDA Link
10/2021 - 04/2019
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2020 - 01/2013
2Androgen Receptors (Androgen Receptor)IBA
07/2019 - 07/2015
2Metformin (Glucophage)FDA LinkGeneric
01/2019 - 11/2018
2Indicators and Reagents (Reagents)IBA
01/2019 - 01/2018
2LiraglutideFDA Link
01/2019 - 11/2018
2Keratins (Keratin)IBA
09/2018 - 03/2017
2Hematoxylin (Haematoxylon)IBA
09/2018 - 03/2017
2Eosine Yellowish-(YS) (Eosin)IBA
09/2018 - 03/2017
2Trastuzumab (Herceptin)FDA Link
09/2018 - 04/2017
2Epidermal Growth Factor (EGF)IBA
01/2015 - 01/2014
2Estrogen ReceptorsIBA
01/2015 - 01/2014
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2022
1Angiotensin Receptor AntagonistsIBA
01/2022
1Apolipoprotein B-48IBA
01/2022
1Apolipoprotein B-100 (Apo B 100)IBA
01/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2022
1Apoprotein(a) (Apolipoprotein (a))IBA
01/2022
1Apolipoprotein C-II (ApoC2)IBA
01/2022
1Thyroid Nuclear Factor 1IBA
01/2022
1ApolipoproteinsIBA
01/2022
1Apolipoprotein C-IIIIBA
01/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1Mineralocorticoid Receptor AntagonistsIBA
01/2022
1Neprilysin (Neutral Endopeptidase)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
11/2021
1C-Reactive ProteinIBA
11/2021
1MART-1 AntigenIBA
10/2021
1SynaptophysinIBA
09/2021
1pro-gastrin-releasing peptide (31-98)IBA
08/2021
1antigen CYFRA21.1IBA
08/2021
1Tumor Biomarkers (Tumor Markers)IBA
08/2021
1AntigensIBA
06/2021
1insulin receptor-related receptor (IRR)IBA
06/2021
1Antihypertensive Agents (Antihypertensives)IBA
06/2021
1FurinIBA
05/2021

Therapy/Procedure

18Therapeutics
01/2022 - 01/2009
6Drug Therapy (Chemotherapy)
06/2021 - 12/2014
4Radiotherapy
01/2021 - 09/2011
2Hysterectomy
08/2022 - 07/2011
2Immunotherapy
01/2021 - 01/2021
1Length of Stay
01/2022
1Nephrectomy
10/2021
1Castration
08/2021
1Percutaneous Coronary Intervention
05/2021